Imaging of the colon in inflammatory bowel disease: Ready for prime time?

Current Drug Targets

Volumn 13, Issue 10, 2012, Pages 1252-1260

  Ordás, Ingrid ^a   Rimola, Jordi ^b   Rodríguez, Sonia ^b   Gallego, Marta ^a   Ricart, Elena ^a   Panés, Julián ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Computed tomography; Crohn's disease; Endoscopy; Inflammatory bowel disease; Magnetic resonance imaging; Ulcerative colitis; Ultrasonography

Indexed keywords

ABSCESS; ARTICLE; COLON; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE SEVERITY; ECHOGRAPHY; ENDOSCOPY; ENTERITIS; FISTULA; HUMAN; IMAGING; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION EXPOSURE; SENSITIVITY AND SPECIFICITY; STENOSIS; ULCERATIVE COLITIS;

COLON; HUMANS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING;

EID: 84866540641     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012802429714     Document Type: Article

References (57)

1. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27.
2. Stange EF, Travis SP, Vermeire S, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis 2008; 2: 1-23.
3. Navaneethan U, Parasa S, Venkatesh PG, Trikudanathan G, Shen B. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011; 5: 189-95.
4. Solem CA, Loftus EV, Jr., Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 707-12.
5. Jones J, Loftus EV, Jr., Panaccione R, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008; 6: 1218-24.
6. Desmond AN, Mc Williams S, Maher MM, Shanahan F, Quigley EM. Radiation exposure from diagnostic imaging among patients with gastrointestinal disorders. Clin Gastroenterol Hepatol 2012; 10(3): 259-65.
7. Kroeker KI, Lam S, Birchall I, Fedorak RN. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol 2011; 45: 34-39.
8. Ajaj WM, Lauenstein TC, Pelster G, et al. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut 2005; 54: 257-63.
9. Dinter DJ, Chakraborty A, Brade J, et al. Endoscopy and magnetic resonance imaging in patients with Crohn's disease: a retrospective single-centre comparative study. Scand J Gastroenterol 2008; 43: 207-16.
10. Luboldt W, Bauerfeind P, Wildermuth S, Debatin JF. Contrast optimization for assessment of the colonic wall and lumen in MR colonography. J Magn Reson Imaging 1999; 9: 745-750.
11. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn's disease. Clin Radiol 2002; 57: 913-8.
12. Pilleul F, Godefroy C, Yzebe-Beziat D, Dugougeat-Pilleul F, Lachaux A, Valette PJ. Magnetic resonance imaging in Crohn's disease. Gastroenterol Clin Biol 2005; 29: 803-8.
13. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001; 177: 1325-32.
14. Schreyer AG, Golder S, Scheibl K, et al. Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: first clinical experience. Inflamm Bowel Dis 2005; 11: 388-94.
15. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005; 3: 1221-8.
16. van Gemert-Horsthuis K, Florie J, Hommes DW, et al. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla. J Magn Reson Imaging 2006; 24: 340-8.
17. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009; 58: 1113-20.
18. Rimola J, Ordas I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17: 1759-68.
19. Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010; 59: 1056-65.
20. Hyun SB, Kitazume Y, Nagahori M, et al. Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn's disease. Inflamm Bowel Dis 2011; 17: 1063-72.
21. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis 2011; 17: 1073-80.
22. Gourtsoyianni S, Papanikolaou N, Amanakis E, et al. Crohn's disease lymphadenopathy: MR imaging findings. Eur J Radiol 2009; 69: 425-8.
23. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 2008; 247: 64-79.
24. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 2004; 14: 1017-24.
25. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009; 252: 712-20.
26. Lauenstein TC. MR colonography: current status. Eur Radiol 2006; 16: 1519-26.
27. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006; 55: 1561-7.
28. Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA. MR motility imaging in Crohn's disease improves lesion detection compared with standard MR imaging. Eur Radiol 2010; 20: 1945-51.
29. Brozna JP, Fisher RL, Barwick KW. Filiform polyposis: an unusual complication of inflammatory bowel disease. J Clin Gastroenterol 1985; 7: 451-8.
30. Low RN, Francis IR, Politoske D, Bennett M. Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000; 11: 127-35.
31. Neurath MF, Vehling D, Schunk K, et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18Ffluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 2002; 97: 1978-85.
32. Panes J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011; 34: 125-45.
33. Allez M, Lemann M, Bonnet J, Cattan P, Jian R, Modigliani R. Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol 2002; 97: 947-53.
34. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2-versus T1-weighted gadoliniumenhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006; 238: 517-30.
35. Pascu M, Roznowski AB, Muller HP, Adler A, Wiedenmann B, Dignass AU. Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel. Inflamm Bowel Dis 2004; 10: 373-82.
36. Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV, Jr. Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. Inflamm Bowel Dis 2008; 14: 1701-6.
37. Herrmann KA, Michaely HJ, Seiderer J, Ochsenkuehn T, Reiser MF, Schoenberg SO. The "star-sign" in magnetic resonance enteroclysis: a characteristic finding of internal fistulae in Crohn's disease. Scand J Gastroenterol 2006; 41: 239-41.
38. Martinez MJ, Ripolles T, Paredes JM, Blanc E, Martí-Bonmatí L. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 2009; 34: 141-8.
39. Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011; 17: 984-93.
40. Thienpont C, D'Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut 2010; 59: 320-4.
41. Hoffmann JC, Heller F, Faiss S, et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis 2008; 23: 689-96.
42. Magnano G, Granata C, Barabino A, et al. Polyethylene glycol and contrast-enhanced MRI of Crohn's disease in children: preliminary experience. Pediatr Radiol 2003; 33: 385-91.
43. Bru C, Sans M, Defelitto MM, et al. Hydrocolonic sonography for evaluating inflammatory bowel disease. AJR Am J Roentgenol 2001; 177: 99-105.
44. Parente F, Greco S, Molteni M, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther 2003; 18: 1009-16.
45. Bremner AR, Griffiths M, Argent JD, Fairhurst JJ, Beattie RM. Sonographic evaluation of inflammatory bowel disease: a prospective, blinded, comparative study. Pediatr Radiol 2006; 36: 947-53.
46. Limberg B, Osswald B. Diagnosis and differential diagnosis of ulcerative colitis and Crohn's disease by hydrocolonic sonography. Am J Gastroenterol 1994; 89: 1051-7.
47. Antonelli E, Giuliano V, Casella G, et al. Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: comparison with endoscopic findings. Dig Liver Dis 2011; 43: 703-6.
48. Ripolles T, Martinez MJ, Paredes JM, Blanc E, Flors L, Delgado F. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009; 253: 241-8.
49. Giovagnoni A, Misericordia M, Terilli F, Brunelli E, Contucci S, Bearzi I. MR imaging of ulcerative colitis. Abdom Imaging 1993; 18: 371-5.
50. Madsen SM, Thomsen HS, Munkholm P, Dorph S, Schlichting P. Active Crohn's disease and ulcerative colitis evaluated by low-field magnetic resonance imaging. Scand J Gastroenterol 1998; 33: 1193-200.
51. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Pediatr Int 2000; 42: 285-8.
52. Maccioni F, Colaiacomo MC, Parlanti S. Ulcerative colitis: value of MR imaging. Abdom Imaging 2005; 30: 584-92.
53. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics 2009; 29: 701-19.
54. Gore RM. Colonic contour changes in chronic ulcerative colitis: reappraisal of some old concepts. AJR Am J Roentgenol 1992; 158: 59-61.
55. Kilickesmez O, Soylu A, Yasar N, et al. Is quantitative diffusionweighted MRI a reliable method in the assessment of the inflammatory activity in ulcerative colitis? Diagn Interv Radiol 2010; 16: 293-8.
56. D'Haens GR, Fedorak R, Lemann M, et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis 2009; 15: 1599-604.
57. Pariente B, Cosnes J, Danese S, et al. Development of the Crohn's disease digestive damage score, the Lemann score. Inflamm Bowel Dis 2011; 17: 1415-22.